스타틴치료후에도 남아있는 심혈관질환의 위험성.pdf가천의과학대학교 길병원 심장내과
박예민·고광곤
Residual Cardiovascular Risk Remains Despite of Statin Treatment:
Importance of High-Density Lipoprotein Cholesterol
Yae Min Park and Kwang Kon Koh
Division of Cardiology, Gachon University Gil Hospital,
Gachon University of Medicine and Science, Incheon, Korea
Lowering low-density lipoprotein-cholesterol (LDL-C) is the primary target to prevent cardiovascular events in patients with dyslipidemia at high risk for cardiovascular disease. Many patients on statin therapy have initial or recurrent coronary heart disease events despite reductions in LDL-C. Indeed, 2/3 of patients on statin therapy suffer from residual risk. Low high-density lipoprotein-cholesterol (HDL-C) and high triglycerides levels are modifiable and important factors to resolve a residual risk. Especially, low serum levels of HDL-C (< 40 mg/dL for men, < 50 mg/dL for women) are highly prevalent and are recognized as an independent risk factor for cardiovascular morbidity (myocardial infarction, stroke, peripheral arterial disease, and restenosis after coronary stenting) and mortality. Thus, therapy focusing on raising HDL-C may be an important paradigm for treating and slowing progression of atherosclerosis, coronary heart disease, and co-morbid metabolic disorders. In this review, we discuss the importance of HDL-C based on experimental and large scaled clinical trials.
(Korean J Med 2011;80:397-401)
Keywords: Dyslipidemia; High-density lipoprotein chole; Cardiovascular disease
'[ 주제별 ] > 심혈관질환' 카테고리의 다른 글
| LDL 콜레스테롤을 낮추면 낮출수록 좋다는 학설에의 이의 제기 (0) | 2018.02.28 |
|---|---|
| What is the optimal strategy for CV risk reduction? (0) | 2018.02.28 |
| 잔여 심혈관 위험과 고중성지방혈증 및 저HDL콜레스테롤혈증 (0) | 2018.02.28 |
| 스타틴을 통한 residual CV risk 관리 (0) | 2018.02.28 |
| 심혈관질환과 당뇨병 (0) | 2017.03.24 |